Cordon-Cardo C - Search Results

1

p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.

Esteller M, Cordon-Cardo C, Corn PG, Meltzer SJ, Pohar KS, Watkins DN, Capella G, Peinado MA, Matias-Guiu X, Prat J, Baylin SB, Herman JG. Esteller M, et al. Cancer Res. 2001 Apr 1;61(7):2816-21. Cancer Res. 2001. PMID: 11306450

2

Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.

Lu ML, Wikman F, Orntoft TF, Charytonowicz E, Rabbani F, Zhang Z, Dalbagni G, Pohar KS, Yu G, Cordon-Cardo C. Lu ML, et al. Clin Cancer Res. 2002 Jan;8(1):171-9. Clin Cancer Res. 2002. PMID: 11801555

3

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays.

Aleman A, Adrien L, Lopez-Serra L, Cordon-Cardo C, Esteller M, Belbin TJ, Sanchez-Carbayo M. Aleman A, et al. Br J Cancer. 2008 Jan 29;98(2):466-73. doi: 10.1038/sj.bjc.6604143. Epub 2007 Dec 18. Br J Cancer. 2008. PMID: 18087279 Free PMC article.

4

p63 expression profiles in human normal and tumor tissues.

Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C. Di Como CJ, et al. Clin Cancer Res. 2002 Feb;8(2):494-501. Clin Cancer Res. 2002. PMID: 11839669

5

MDM2 and prognosis.

Onel K, Cordon-Cardo C. Onel K, et al. Mol Cancer Res. 2004 Jan;2(1):1-8. Mol Cancer Res. 2004. PMID: 14757840 Review.

6

Identification of PMF1 methylation in association with bladder cancer progression.

Aleman A, Cebrian V, Alvarez M, Lopez V, Orenes E, Lopez-Serra L, Algaba F, Bellmunt J, López-Beltrán A, Gonzalez-Peramato P, Cordon-Cardo C, García J, del Muro JG, Esteller M, Sánchez-Carbayo M. Aleman A, et al. Clin Cancer Res. 2008 Dec 15;14(24):8236-43. doi: 10.1158/1078-0432.CCR-08-0778. Clin Cancer Res. 2008. PMID: 19088041

7

Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.

Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ. Cordon-Cardo C, et al. Cancer Res. 1994 Feb 1;54(3):794-9. Cancer Res. 1994. PMID: 8306343

8

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.

Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordón-Cardó C, Lowe SW. Soengas MS, et al. Nature. 2001 Jan 11;409(6817):207-11. doi: 10.1038/35051606. Nature. 2001. PMID: 11196646

9

Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma.

Ho GH, Calvano JE, Bisogna M, Abouezzi Z, Borgen PI, Cordón-Cardó C, van Zee KJ. Ho GH, et al. Breast Cancer Res Treat. 2001 Feb;65(3):225-32. doi: 10.1023/a:1010686518990. Breast Cancer Res Treat. 2001. PMID: 11336244

10

Tumor promotion by Mdm2 splice variants unable to bind p53.

Fridman JS, Hernando E, Hemann MT, de Stanchina E, Cordon-Cardo C, Lowe SW. Fridman JS, et al. Cancer Res. 2003 Sep 15;63(18):5703-6. Cancer Res. 2003. PMID: 14522887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

646 results

Search Page

Filters